Drug intelligence / Profile preview

Hu-lu-ba-wan

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Hu-lu-ba-wan is a traditional Chinese herbal formula primarily used to treat kidney deficiency and related conditions. The name "Hu Lu Ba" refers to fenugreek seeds (Trigonella foenum-graecum), which are a key ingredient in the formula. In Traditional Chinese Medicine (TCM), this prescription is believed to warm the kidneys, tonify yang, dissipate cold, and ease pain. It has been studied for its potential effects in attenuating diabetic nephropathy by modulating oxidative stress and inflammation pathways[7]. The mechanism of action is thought to involve antioxidant and anti-inflammatory effects as well as possible modulation of blood sugar metabolism[7][1][5]. Other ingredients may be present depending on the specific formulation.

Brand names: Hu-lu-ba-wan
Other names: HLBW胡蘆巴丸Hu Lu Ba Wan

Beyond the preview

Go deeper on Hu-lu-ba-wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hu-lu-ba-wan.

Explore the full profile